Literature DB >> 31215655

The effect of insights on medication adherence in patients with schizophrenia.

Eda Kalkan1, Funda Kavak Budak2.   

Abstract

PURPOSE: This study was conducted to identify the effect of insights on medication adherence in patients with schizophrenia. DESIGN AND METHODS: This is a cross-sectional study conducted between June 2017 and June 2018 in the Elazig Mental Health and Diseases Hospital. The sample of the study was determined as 300 patients with schizophrenia with the power analysis. Descriptive Characteristics Form, Birchwood Insight Scale, and Morisky Medication Adherence Scale were used to collect the data. In the analysis of data, percentage, arithmetic mean, independent samples t test, the Kruskal Wallis test, analysis of variance, regression analysis, and post hoc-Tukey tests were used.
FINDINGS: Approximately 69% of the patients had a moderate level of medication adherence and moderate insight. There was a statistically positive strong correlation between the insights and medication adherence of the patients (P < .05). PRACTISE IMPLICATIONS: The patients with schizophrenia had low insight and moderate medication adherence and as their insight increased their medication adherence increased.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  insight; medication adherence; patient; schizophrenia

Mesh:

Substances:

Year:  2019        PMID: 31215655     DOI: 10.1111/ppc.12414

Source DB:  PubMed          Journal:  Perspect Psychiatr Care        ISSN: 0031-5990            Impact factor:   2.186


  4 in total

1.  Olfactory training ball improves adherence and olfactory outcomes in post-infectious olfactory dysfunction.

Authors:  Ozlem Saatci; Aytug Altundag; Ozge Arici Duz; Thomas Hummel
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-04-03       Impact factor: 2.503

2.  Risk factors for readmission in schizophrenia treated with combined psychoeducation and standard therapy.

Authors:  Satoru Sugisawa; Tatsuya Kurihara; Yukako Nakano; Toshiaki Tsuneoka; Hiroaki Koya; Tsutomu Nagai; Tomohiro Ikeda; Naoko Fujisawa; Atsuko Inamoto; Akira Iwanami
Journal:  Neuropsychopharmacol Rep       Date:  2022-01-26

3.  Improving Medication Adherence in Community-Dwelling Patients with Schizophrenia Through Therapeutic Alliance and Medication Attitude: A Serial Multiple Mediation Model.

Authors:  Wen Ling Hsieh; Shin Ting Yeh; Wen I Liu; I Hsien Li; Shih Kai Lee; Wai Tong Chien
Journal:  Patient Prefer Adherence       Date:  2022-04-13       Impact factor: 2.314

4.  Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post-hoc analysis of a long-term open-label study.

Authors:  Jun Ishigooka; Ken Inada; Kazunari Niidome; Kazuo Aoki; Yoshitsugu Kojima; Shuichi Iwashita; Sakiko Yamada
Journal:  Hum Psychopharmacol       Date:  2021-01-26       Impact factor: 1.672

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.